Sorrento Therapeutics Stock Price (NASDAQ:SRNE)

Add to My Stocks
$3.65 $0.47 (14.78%) SRNE stock closing price Dec 28, 2017 (Closing)
Prev Close* : $3.18
Market Cap:
Day Low: $3.2
52 Week Low: $1.50
Open: $3.25
Volume: 1,517,435
Day High: $3.7
52 Week High: $6.08

Latest Stock Market News

Latest Articles

Sorrento Therapeutics News - From Partners

Last Analytics

macys ticker symbol today ipo listing new dow jones industrial averages chart berkshire hathaway stock quote dow historical chart con edison stock symbol historical chart dow jones hershey stock ticker stock quotes xom historical chart of dow jones share price of santander nyse berkshire hathaway

SRNE Stockcharts

View SRNE PE ratio, PS ratio stocks charts and compare with peers.
Note: Compare Sorrento Therapeutics stock price history with the index and industry peers.

Sorrento Therapeutics Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Sorrento Therapeutics Returns

(return on equity)

Sorrento Therapeutics Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

SRNE Industry Peers

Company Price Change (%)
Nabriva Therapeutics (NBRV)6.250.02 (0.32%)
Nymox Pharmaceutical (NYMX)3.340.05 (1.52%)
Evotec (EVTCY)33.10.04 (0.12%)
Bristol-myers Squibb (BMY)61.770.09 (0.15%)
Receptos (RCPT)231.960.03 (0.01%)
Critical Outcome (COTQF)10 (0%)
Intrexon (XON)11.330.28 (2.41%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Fortress Biotech (FBIO)40.64 (19.05%)
Sorrento Therapeutics (SRNE)3.650.48 (15.12%)
Curis (CRIS)0.730.04 (5.8%)
IOVANCE BIOTHPT (IOVA)8.30.3 (3.75%)
Keryx Biopharma (KERX)4.720.17 (3.74%)
Eiger Biopharma (EIGR)13.950.5 (3.72%)
Immunomedics (IMMU)16.320.57 (3.62%)
Top gainers from Medical-Biomed-Genetics industry
* As of Dec 29, 2017
CompanyPriceChange (%)
Fate Therapeutics (FATE)6.090.55 (8.28%)
Bio-Rad Labs (BIO.B)238.2517 (6.66%)
Peregrine Pharma (PPHM)4.030.17 (4.05%)
AMAG Pharma (AMAG)13.450.5 (3.58%)
Xoma (XOMA)35.541.25 (3.4%)
Alder BioPharma (ALDR)11.450.4 (3.38%)
Inovio Pharma (INO)4.140.12 (2.82%)
Top losers from Medical-Biomed-Genetics industry
* As of Dec 29, 2017

Sorrento Therapeutics Inc Stock News - Partner Headlines

Sorrento Therapeutics Financial Statements

income statement20162015201420132012
Net Sales or Revenues8.15M4.59M3.82M0.46M0.58M
Net Income-60.92M-45.81M-34.65M-21.91M-4.84M
Total Operating Expense104.1M76.63M36.51M22.11M5.43M
View Sorrento Therapeutics income statement
balance sheet20162015201420132012
Total Assets401.58M343.51M141.54M92.58M6.78M
Total Liabilities315.08M202.58M32.82M25.77M0.58M
Shareholders Equity86.5M140.93M108.71M66.8M6.19M
View Sorrento Therapeutics balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities25.6M14.8M-0.22M0.43M-0.1M
Net Cash from (used by) Operating Activities-70.89M-42.06M-28.76M-16.48M-3.79M
Increase (Decrease) in Prop Plant And Equipment-6.86M-3.7M-0.59M-0.42M-0.54M
View Sorrento Therapeutics cash flow statement

Sorrento Therapeutics Stock Message Board

An investor needs to spend $3.65 to buy SRNE stock, as the closing Sorrento Therapeutics stock price is $3.65. The total market value as denoted by $262.55M for Sorrento Therapeutics, is the market value of the company's outstanding shares. Sorrento Therapeutics valuation can be guaged using various valuation metrics like the price to earnings ratio.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Sorrento Therapeutics is worth a lot, it will most likely be reflected in an inflated Sorrento Therapeutics stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 1,517,435 SRNE shares were traded yesterday, and Sorrento Therapeutics stock chart shows that the SRNE stock quote hit a day high of $3.7 and day low of $3.2. Sorrento Therapeutics paid 0.00 stock dividends to its shareholders during last quarter. To check the historical stock price movement, all time high, and all time low of SRNE, view Sorrento Therapeutics stock price history.